Merck Profit Beats Second-Quarter Estimates, Target Raised

Updated on

Merck & Co. raised its full-year profit guidance and reported second-quarter earnings that beat estimates despite falling sales of some top drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.